2019
DOI: 10.4274/jcrpe.galenos.2018.2018.0182
|View full text |Cite
|
Sign up to set email alerts
|

Efficiency of Single Dose of Tolvaptan Treatment During the Triphasic Episode After Surgery for Craniopharyngioma

Abstract: Inappropriate antidiuretic hormone syndrome (SIADH) may develop after intracranial surgery. SIADH in the pediatric age group is usually encountered in patients with an intracranial mass both before and after surgery. Fluid restriction is the standard therapy in SIADH. However, a resistant, hyponatremic pattern may be encountered in some cases. Vaptans have been recently introduced for treatment of hyponatremia due to SIADH. There is inadequate data concerning tolvaptan treatment in pediatric patients. We prese… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(4 citation statements)
references
References 20 publications
0
4
0
Order By: Relevance
“…It is safe to correct hyponatremia by 6–8 mmol/L per day. However, the rapid correction of hyponatremia can be life‐threatening and leads to osmotic demyelination syndrome (Gürbüz et al., 2019 ). For patients with CSW, immediate fluid resuscitation is recommended to restore blood volume and increase serum Na + levels.…”
Section: Discussionmentioning
confidence: 99%
“…It is safe to correct hyponatremia by 6–8 mmol/L per day. However, the rapid correction of hyponatremia can be life‐threatening and leads to osmotic demyelination syndrome (Gürbüz et al., 2019 ). For patients with CSW, immediate fluid resuscitation is recommended to restore blood volume and increase serum Na + levels.…”
Section: Discussionmentioning
confidence: 99%
“…Reports of tolvaptan use for SIADH in children are limited [ 6 , 7 , 8 , 9 , 10 , 11 ]. The reported pediatric patients are summarized in Table 2 .…”
Section: Discussionmentioning
confidence: 99%
“…Excessive correction of hyponatremia was observed in 23% of patients, all these patients having baseline serum Na <125 mmol/L, but no cases of ODS were recorded [31]. Even a single dose of tolvaptan can be sufficient to correct hyponatremia in some children [32]. Tolvaptan recently has been implicated in causing serum aminotransferase elevation as well as clinically apparent acute liver injury by idiosyncrasy.…”
Section: Early Postoperative Fluid-electrolyte Disturbancesmentioning
confidence: 99%